News
November 17, 2010 – Atrial fibrillation (AFib) patients treated with catheter ablation reported fewer symptoms and improved quality of life, according to data from Circulation Cardiovascular Quality and Outcomes. The patients, who were treated with Biosense Webster’s NaviStar ThermoCool catheter, were compared with patients treated with antiarrhythmia drugs.
November 17, 2010
News
November 17, 2010 – A drug-eluting balloon (DEB) and a coronary stent have received CE mark approval in Europe. The DEB and the coronary CoCr stent, both by Blue Medical, have been approved for treating coronary diseases. DEB therapy delivers a controlled dose of Paclitaxel to the coronary artery during balloon angioplasty.
November 17, 2010News
November 17, 2010 - Results from the GRAVITAS Trial found that doubling the maintenance dose of clopidogrel (Plavix) did not reduce the risk of further ischemic events after percutaneous coronary intervention (PCI).
November 17, 2010Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News
November 16, 2010 – A new tool for personalized preventative medicine was introduced at the American Heart Association Scientific Sessions 2010. Panasonic’s CardioHealth Station is designed to assist medical professionals in making a quick and valuable assessment of cardiovascular health.
November 16, 2010
Technology
November 16, 2010 – An all-in-one micropuncture radial access kit is now available in the United States. The Glidesheath Nitinol Kit, by Terumo Interventional Systems, is for physicians who prefer transradial interventional procedures.
November 16, 2010Technology
November 16, 2010 – A joint partnership between AirStrip Technologies and Physio-Control will allow the two companies to deliver integrated, lifesaving mobile solutions.
November 16, 2010Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News
November 16, 2010 – Study results show that pacemaker patients without history of atrial tachycardia (AT) or atrial fibrillation (AF) who have device-detected arrhythmias are more likely to have a stroke than patients who don’t have device-detected arrhythmias. The ASSERT Trial, sponsored by St. Jude, found that those patients are approximately 2.5 times more likely to have a stroke.
November 16, 2010
News
November 16, 2010 – Analysis of data from the PARTNER trial showed that patients implanted with transcatheter heart valve not only experienced improved survival, but also substantially better quality of life. The results, which were presented at the American Heart Association's Scientific Sessions 2010, focused on the Sapien transcatheter heart valve, by Edwards.
November 16, 2010News
November 16, 2010 – Results from the ROCKET AF trial showed that rivaroxaban given once daily is superior at reducing stroke and non-central nervous system (CNS) systemic embolism in patients with atrial fibrillation (AF). The trial compared the drug with warfarin, the most common stroke-prevention medicine in AF patients.
November 16, 2010Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Technology
November 16, 2010 – New telemedicine technology allows physicians to transfer digitally captured patient sounds in real time. The Littman Scope-to-Scope Tele-Auscultation System, by 3M, can literally enable a doctor in Minnesota to detect a heart murmur in a child in rural Arizona. The system works with the company’s Littman Electronic Stethoscope Model 3200.
November 16, 2010News
November 15, 2010 - An experimental pump implanted in patients waiting for a heart transplant works as well as approved devices, according to trial results presented at the American Heart Association’s Scientific Sessions 2010.
November 15, 2010
News
November 15, 2010 — With regard to its molecular imaging business, GE Healthcare announced an agreement to acquire the assets of OMS, a subsidiary of Orbotech, a publicly held company based in Yavne, Israel. OMS manufactures cadmium zinc telluride (CZT) detector technology, a key component of GE Healthcare’s Alcyone nuclear medicine platform.
November 15, 2010Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News
November 15, 2010 - A catheter procedure that closes a hole in patients’ hearts appears to be no more effective than drug therapy in preventing recurrent strokes, according to trial results presented at the American Heart Association’s Scientific Sessions.
November 15, 2010
News
November 15, 2010 – Data from the RAFT clinical trial show that cardiac resynchronization therapy-defibrillators (CRT-Ds) significantly reduced mortality for mildly symptomatic heart failure patients. The trial looked at Medtronic CRT-Ds.
November 15, 2010News
November 15, 2010 – The registry for a study designed to test the effectiveness of coronary computed tomographic angiography (CCTA) for diagnosing coronary artery disease (CAD) was announced at the American Heart Association (AHA) Scientific Session. The CONFIRM study spans six countries and will look at more than 27,000 patients.
November 15, 2010© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now